It is currently the only vaccine authorized by the Drug Controller General of India (DCGI) for active immunization against HEV in adults aged 18 to 65
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
Once finalized, cough syrups will no longer be available for over-the-counter sale
Adverse events were consistent with valbenazine’s established safety profile
The MAR-Autism Test represents more than 20 years of research at the UC Davis MIND Institute by Judy Van de Water
The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
Alphyn is developing Zabalafin Hydrogel as the first therapy to simultaneously tackle the interconnected drivers of AD
Subscribe To Our Newsletter & Stay Updated
